Intact Investment Management Inc. Imv Inc. Transaction History

Intact Investment Management Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$2.25 - $3.82 $545,440 - $926,036	-242,418 Closed	0 $0
Q2 2019 Jul 30, 2019	BUY	$2.75 - $4.5 $550 - $900	200 Added 0.08%	242,418 $902,000
Q2 2018 Jul 25, 2018	BUY	$4.42 - $7.13 $1.07 Million - $1.73 Million	242,218 New	242,218 $1.61 Million

Ticker IMV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,452,200
Description
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is P...

Get notified when there are updates to the investment portfolio of Intact Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Intact Investment Management Inc. with notifications on news.